Published on 5 Aug 2021 on Zacks via Yahoo Finance
Acorda Therapeutics (ACOR) came out with a quarterly loss of $2.29 per share versus the Zacks Consensus Estimate of a loss of $2.09. This compares to loss of $2.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -9.57%. A quarter ago, it was expected that this drugmaker would post a loss of $2.54 per share when it actually produced a loss of $2.46, delivering a surprise of 3.15%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.